Fibrin und tumorassoziierte Antigene in ihrer Beziehung zur Ausbreitung des Ovarialkarzinoms

 

^* Institut für Pathologie und Pathologische Anatomie der Technischen Universität München, München

• Literatur

• 1 Markus G. The role of hemostasis and fibrinolysis in the metastatic spread of cancer. Sem Thromb Hemost 1984; 10: 61-70.
• 2 Graeff H, Hafter R. Clinical aspects of fibrinolysis. In: Hemostasis and Thrombosis. Bloom A.L. et al. (Hrsg) Sec Ed. London: Churchill Livingstone; 1986
• 3 Graeff H, Hafter R, Bachmann L. Subunit and macromolecular structure of circulating fibrin from obstetrical patients with intravascular coagulation. Thromb Res 1979; 16: 313-28.
• 4 Graeff H, Hafter R. Detection and relevance of crosslinked fibrin derivatives in blood. Sem Thromb Hemost 1982; 8: 57-68.
• 5 Hafter R, Klaubert W, Gollwitzer R, von Hugo R, Graeff H. Cross-linked fibrin derivatives and fibronectin in ascitic fluid from patients with ovarian cancer compared to ascitic fluid in liver cirrhosis. Thromb Res 1984; 35: 53-64.
• 6 Rylatt D.B, Blake A.S, Cottis L.E, Messing-ham D.A, Fletcher W.A, Masci P.P, Whitaker A.N, Elms M, Bunce J, Webber A.J, Wyatt D, Bundesen P.G. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983; 31: 767-78.
• 7 Hafter R, Schröck R, von Hugo R, Graeff H. Measurement of cross-linked fibrin derivatives in plasma and ascitic fluid with monoclonal antibodies against D-dimer using EIA and latex test. Scand Clin Lab Invest 1985; 45 suppl. 0178 137-44.
• 8 Schröck R, Hafter R, Schmid L, Babic R, Ulm K, Gössner W, Graeff H. Tumorassoziierte Antigene und Fibrinderivate als Reaktionsprodukte des Ovarialkarzinoms. Geburtshilfe Frauenheilkd 1986; 46: 1-10.
• 9 Schlegel G, Lüthgens M, Eklund G, Björk-lund B. Correlation between activity in breast cancer and CEA, TPA, and eighteen common laboratory procedures and the’improvement by the combined use of CEA and TPA. Tumor-Diagnostik 1981; 2: 6-11.
• 10 Bast R.C, Fung M, Lazarus H, Nadler L.M, Colvin R.B, Knapp R.C. Reactivity of monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981; 68: 1331-7.
• 11 Kabawat S.E, Bast R.C, Welch R, Knapp R.C, Colvin R.B. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of ovarian tumours of serous, endometrioid, and clear cell types. Am J Clin Pathol 1983; 79: 98-104.
• 12 Koprowski H, Steplewski Z, Micheli K, Herlyn M, Herlyn D, Fuhrer P. Colorectal antigens detected by hybridoma antibodies. Somatic Cell Genet 1979; 5: 957-72.
• 13 Gold P, Freedman S.O. Specific carcino-embryonic antigens of the human digestive system. J Exp Med 1965; 122: 467-81.
• 14 Björklund B. On the nature and clinical use of tissue polypeptide antigen (TPA). Tumor-Diagnostik 1980; 1: 9-20.
• 15 Whitaker A.N, Elms M.J, Masci P.P, Bundesen P.G, Rylatt D.B, Webber A.J, Bunce I. Measurement of crosslinked fibrin derivatives in plasma. J Clin Path 1984; 37: 882-7.
• 16 Ruoslahti E, Hayman E.G, Pierschbacher M, Engvall E. Fibronectin: Purification, immunochemical properties and biological activities. In: Methods of Enzymology, Vol 82. Colowick S.P, Kaplan N.O. (Hrsg) New York: Academic Press; 1982: 803-31.
• 17 Oehr P, Derigs G, Altmann R. Evaluation and characterization of tumor associated antigens by conversion of inverse distribution function values into specificity-sensitivity diagrams. Tumor-Diagnostik 1981; 2: 283-90.
• 18 Hanley J.A, McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.
• 19 Hanley J.A, McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
• 20 Lane D.A, Scully M.F, Kakkar V.V. A method for characterising serum fibrinogen and fibrin degradation products. Thromb Res 1976; 9: 191-200.
• 21 Sternberger L.A, Hardy H.P, Cuculis J.H, Meyer H.E. The unlabelled antibody enzyme method for immunohistochemistry. Histochem Cytochem 1970; 18: 315-33.
• 22 Hafter R, Schröck R, von Hugo R, Graeff H. Clinical aspects of fibrin formation and fibrinolysis measured with monoclonal antibodies against D-Dimer. In: Fibrinogen-Fibrin Formation and Fibrinolysis, Vol 4. Lane D.A. et al. (Hrsg) Berlin: de Gruyter; 1986: 302-12.
• 23 Henderson J.M, Stein S.T, Kutner M, Wiles M.B, Ansley J.D, Rudman D. Analysis of twenty-three plasma proteins in ascites. The depletion of fibrinogen and plasminogen. Ann Surg 1980; 192: 738-42.
• 24 Svanberg L, Astedt B. Coagulative and fibrinolytic properties of ascitic fluid associated with ovarian tumors. Cancer 1975; 35: 1382-7.